| abstract |
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP), in which the formulations have increased increased resistance to microbial contamination and is comprised of a Y2 receptor-binding peptide, water, a cyclodextrin and sodium benzoate, and in which the formulations have increased stability, have an osmolarity of from about 200 mOsm and 300 mOsm and are substantially free of sugars and sugar alcohols. |